Similar companies
Did West Pharmaceutical Services Beat Earnings?
West Pharmaceutical Services (WST) reported Q2 '26 revenue of $872M, up 13.8% year-over-year, with reported EPS of $2.37. That topped the $2.08 analyst estimate by 13.9% — an earnings beat.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — West Pharmaceutical Services’s job postings, web traffic, and employee business outlook. See the full WST stock analysis or the earnings calendar for upcoming reports.
WST Earnings Surprise History (EPS vs. Estimate)
| Quarter | Estimated EPS | Reported EPS | Surprise |
|---|---|---|---|
| Q2 '26 | $2.08 | $2.37 | Beat +13.9% |
| Q1 '26 | $1.68 | $2.13 | Beat +26.8% |
| Q4 '25 | $1.83 | $2.04 | Beat +11.5% |
| Q3 '25 | $1.71 | $1.96 | Beat +14.6% |
| Q2 '25 | $1.54 | $1.84 | Beat +19.5% |
| Q1 '25 | $1.26 | $1.45 | Beat +15.1% |
West Pharmaceutical Services Quarterly Financial Trends
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 747M | 749M | 698M | 766M | 804M | 805M | 845M | 872M |
| Gross margin | 35.5% | 36.7% | 33.3% | 35.7% | 36.5% | 37.8% | 35.1% | 37.7% |
| Operating margin | 22.5% | 22.8% | 18.4% | 20.6% | 21.6% | 19.5% | 21.0% | 20.5% |
| Net income | 136M | 130M | 90M | 132M | 140M | 132M | 139M | 154M |
| Net margin | 18.2% | 17.4% | 12.9% | 17.2% | 17.4% | 16.4% | 16.4% | 17.7% |
| EPS | $1.85 | $1.82 | $1.45 | $1.84 | $1.96 | $2.04 | $2.13 | $2.37 |
West Pharmaceutical Services Earnings Trend Analysis
Over the eight quarters from Q3 '24 to Q2 '26, West Pharmaceutical Services’s quarterly revenue moved from $747M to $872M. Net margin held roughly steady from 18.2% to 17.7%, against a 37.7% gross margin in the most recent quarter — a read on whether revenue growth is translating into profit. West Pharmaceutical Services has beaten Wall Street EPS estimates in 8 of its last 8 reported quarters.
When Is West Pharmaceutical Services’s Next Earnings Date?
West Pharmaceutical Services reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the WST earnings calendar.
Frequently Asked Questions: West Pharmaceutical Services Earnings
West Pharmaceutical Services's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
West Pharmaceutical Services reported Q2 '26 EPS of $2.37 on revenue of $872M (+13.8% YoY). West Pharmaceutical Services beat estimates, reporting $2.37 vs. the $2.08 estimate.
West Pharmaceutical Services reported Q2 '26 revenue of $872M, up 13.8% from the same quarter a year earlier.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the WST AI Score.
